Italia markets closed
  • Dow Jones

    29.638,64
    -271,73 (-0,91%)
     
  • Nasdaq

    12.198,74
    -7,11 (-0,06%)
     
  • Nikkei 225

    26.433,62
    -211,09 (-0,79%)
     
  • EUR/USD

    1,1932
    -0,0039 (-0,32%)
     
  • BTC-EUR

    16.250,29
    +36,93 (+0,23%)
     
  • CMC Crypto 200

    380,85
    +16,25 (+4,46%)
     
  • HANG SENG

    26.341,49
    -553,19 (-2,06%)
     
  • S&P 500

    3.621,63
    -16,72 (-0,46%)
     

Avidity Science™ Expands Biomedical Research Solutions Through Acquisition of Bio Medic Data Systems, Hydropac®, Lab Products, Inc., and Harford Systems

webinfo@adnkronos.com
·2 minuto per la lettura

WATERFORD, Wisconsin, Oct. 26, 2020 /PRNewswire/ -- Today, Avidity Science announces significant steps in expanding its global leadership in biomedical research solutions via the acquisition of Bio Medic Data Systems, Hydropac®, Lab Products, Inc., and Harford Systems. These investments expand Avidity's portfolio of water purification and delivery products, control and monitoring solutions, and service capabilities to enhance its support of the global biomedical research community.

"We are excited about this investment as it adds critical products, capabilities, and services to our industry-leading biomedical research portfolio," said Doug Lohse, chief executive officer, Avidity Science. "Bio Medic Data Systems, Hydropac®, and Lab Products are recognized leaders in innovation, and we will now be able to offer the most comprehensive and technologically-advanced portfolio of products and services to support biomedical research around the world."

"We are confident that Avidity Science will continue supporting our long-standing customers with outstanding innovation, combined with strong product and service offerings. We are excited for our associates to join the growing Avidity Science team and to ensure a smooth business transition," said George Gabriel, Lab Products, Inc., president and chief executive officer.

"With the rapid growth of biomedical research, it is vitally important that Avidity can deliver quality products and services to safeguard the valuable research studies being conducted to support critical and emerging health concerns worldwide," said Laura Sarlin, vice president and head of Avidity's Global Biomedical business.

Lohse concluded, "These investments represent another critical step in achieving our Vision of enabling science to improve the quality of life. Avidity Science has established a diversified solution portfolio and global footprint, strengthening our position as a trusted partner to the research community."

About Avidity ScienceAvidity Science is a worldwide leader in water purification and delivery, control and monitoring and service solutions for the life science and biomedical research communities. Since 1969, our mission has been to enable science to improve the quality of life. With operations in the United States, Europe, and Asia, we are a trusted partner to the global research community through unrivaled technology and support. For more information about these investments and our company, please visit www.AvidityScience.com.